Catalyst Wire Dossier Catalyst Wire Dossier

Aliskiren

Aliskiren · Novartis
Drug timelines are a Plus or Pro feature.

75 regulatory and trial events tracked for Aliskiren, covering 2007-03-05 to 2025-06-22. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy [Phase 2]

See pricing